Delivery Order SPE2DR25D3505-SPE2DR26F97V7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30-count) on January 6, 2026, with a contract ceiling value of $5,823.04 and an ultimate completion date of January 7, 2026. This is a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and running through December 2026. The work will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,521.98 delivery order on December 4, 2025, for the supply of Isotretinoin 40 mg capsules (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 5, 2025, and performance to be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $1,123.46 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Isotretinoin 30 mg capsules (30-count units), with completion scheduled for January 5, 2026. This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,269.27 for 30 mg Isotretinoin capsules (30-count supply) with an ultimate completion date of November 17, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Department of Defense's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 30 units, with a contract ceiling value of $17,955.69. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and was awarded without a set-aside designation, indicating it was awarded through open competition. The contract is executed from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,969.33 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count packaging) with a firm fixed price contract type. The contract was competitively awarded without a set-aside designation and is scheduled for completion by April 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and deliver this pharmaceutical product to...
- The Defense Logistics Agency awarded a delivery order valued at $2,619.93 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,074.58 on November 5, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 6, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units) with a ceiling value of $7,051.35. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,283.59 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count packages) on January 21, 2026, with completion targeted for January 22, 2026. This firm fixed-price, non-set-aside contract will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical...
- SPE2DR25D3505Indefinite Delivery Contract
- SPE2DR25D3505-SPE2DR26F97V7Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 26, 2026, for Isotretinoin 30 mg capsules with a ceiling value of $2,969.01. This non-set-aside, firm fixed-price delivery order is scheduled for completion by January 27, 2026, and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds a significant $999,999,999.00 IDC with the Defense Logistics Agency through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order exemplifies AmerisourceBergen's role as a critical vendor in the federal pharmaceutical supply chain, particularly for military and veteran healthcare systems. Isotretinoin is a specialized dermatological medication used primarily for severe acne treatment. The award reflects the company's demonstrated capability to fulfill federal procurement requirements through open competition and its extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains. As part of the Defense Logistics Agency's pharmaceutical support operations, this contract supports the broader mission of ensuring adequate medical supply availability to military treatment facilities and other federal healthcare institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 1/25/26 |